(1 - 3 von 5
)
Alcanza Trial Demonstrates Highly Statistically Significant...
www.adcreview.com
Alcanza Trial Demonstrates Highly Statistically Significant Improvement in Rate of Objective Response » ADC Review
Takeda reports new data showing effectiveness of cancer drug Adcetris
server88-208-228-57.live-servers.net
Takeda and Seattle Genetics have announced new clinical trial data demonstrating the effectiveness of Adcetris in treating cutaneous T-cell lymphoma.
Takeda reports positive data from Adcetris CTCL study
www.zenopa.com
Takeda and Seattle Genetics' drug Adcetris has demonstrated its effectiveness in the treatment of cutaneous T-cell lymphoma in a new clinical trial.
sortiert nach Relevanz / Datum